FORT MYERS, Fla., Aug. 26, 2016 -- 21st Century Oncology Holdings, Inc. ("21C Holdings" or the "Company"), the largest global, physician led provider of integrated cancer care (“ICC”) services, today announced that it will host a conference call on Wednesday, August 31, 2016 at 11:00 a.m. Eastern Time, during which management will discuss the financial results of the fourth quarter and year ended December 31, 2015 and its restated financial statements for prior periods. The conference call and replay of the conference call may be accessed as follows:
Dial-in numbers: 877-407-9039 (Domestic); 201-689-8470 (International)
Replay Dial-in Numbers (Available until September 14, 2016): 877-870-5176 (Domestic); 858-384-5517 (International); Replay Pin Number: 13644461
A live webcast and webcast replay of the call will also be available from the Events section of the corporate web site at www.21co.com.
About 21st Century Oncology Holdings, Inc.
21st Century Oncology Holdings, Inc. is the largest global, physician led provider of integrated cancer care services. The Company offers a comprehensive range of cancer treatment services, focused on delivering academic quality, cost-effective patient care in personal and convenient settings. As of December 31, 2015, the Company operated 181 treatment centers, including 145 centers located in 17 U.S. states and 36 centers located in seven countries in Latin America.
21st Century Oncology Contact: LeAnne M. Stewart Chief Financial Officer 239-931-7281 [email protected] Investor Contact: The Ruth Group Nick Laudico 646-536-7030 [email protected] Brandon Vazquez 646-536-7032 [email protected]


Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 



